Advertisement

PharmacoEconomics & Outcomes News

, Volume 770, Issue 1, pp 33–33 | Cite as

Xultophy cost effective for T2DM in Sweden

Clinical study

Reference

  1. Ericsson A, et al. Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden. Applied Health Economics and Health Policy : 6 Jan 2017. Available from: URL: http://doi.org/10.1007/s40258-016-0301-y

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations